Combined Photothermal and mTOR‐Targeted Therapy Overcomes Immune Evasion and Enhances Checkpoint Blockade Efficacy in Metastatic Triple‐Negative Breast Cancer
Advanced Science · 2026-02 · 13 (10)
DOI: 10.1002/advs.202513711 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 19.11.2025. Verfasst von Yujie Zhao und 13 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Breast Health Medicine, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center,…. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Immune Checkpoint Inhibitors, Photothermal Therapy, TOR Serine-Threonine Kinases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, Noncommunicable Chronic Diseases-National Science and Technology Major Project, National Natural Science Foundation of China.
Abstract (Originalsprache)
Triple‐negative breast cancer, a representative immune “cold” tumor, resists immune checkpoint blockade (ICB). A promising strategy to overcome this limitation involves combining photothermal therapy (PTT) with ICB. Here, it is demonstrated that while PTT enhances antitumor immunity by inducing immunogenic cell death (ICD), it paradoxically activates the oncogenic mTOR pathway, driving tumor immune evasion. To address this, ASPPR∩A, a mTOR inhibitor‐loaded and pH/NIR‐II‐responsive gold nanocomposite delivering localized hyperthermia and mTOR inhibition, are developed. The nanocomposite selectively targets tumor cells and efficiently converts NIR‐II light into hyperthermia upon laser irradiation. In vitro, the nanocomposite‐mediated photothermal‐mTOR dual‐therapy synergistically enhances ICD and MHC‐I antigen presentation. In murine TNBC models, this combination significantly amplifies ICD and T‐cell infiltration, and synergizes with PD‐1 blockade. Notably, this triple‐combination regimen effectively eliminates distant metastases via systemic antitumor immune response. The findings reveal the paradoxical role of PTT, establishing a photothermal‐targeted‐immune combinatorial paradigm for treating metastatic immune “cold” tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Breast Health Medicine, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, Sichuan, 610041, China.
- Breast Center, West China Hospital, Sichuan University, Chengdu, 610041, China.
- Laboratory of pathology, West China Hospital of Sichuan University, Chengdu, Sichuan, 610041, China.
- Research Core Facility, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China.
- Animal Experimental Center, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China.
ORCID-Profile: Xiaowei Liu
Förderung
- National Key Research and Development Program of China
- Noncommunicable Chronic Diseases-National Science and Technology Major Project
- National Natural Science Foundation of China
- Natural Science Foundation of Sichuan Province
- National Guidance Fund on Developing Local Science and Technology for Sichuan Province
- 1.3.5 project for disciplines of excellence, West China Hospital, Sichuan University
- China Post-doctoral Science Foundation
- Postdoctor Research Fund of West China Hospital, Sichuan University
Zitieren
APA
Zhao, Y., Yu, J., Wang, X., Liu, X., Zuo, F., Xu, T., Tang, L., Xiong, L., Li, L., Li, H., Chen, X., Yang, G., Jing, J., & Liu, X. (2026). Combined Photothermal and mTOR‐Targeted Therapy Overcomes Immune Evasion and Enhances Checkpoint Blockade Efficacy in Metastatic Triple‐Negative Breast Cancer. Advanced Science, 13(10). https://doi.org/10.1002/advs.202513711
Vancouver
Zhao Y, Yu J, Wang X, Liu X, Zuo F, Xu T, et al. Combined Photothermal and mTOR‐Targeted Therapy Overcomes Immune Evasion and Enhances Checkpoint Blockade Efficacy in Metastatic Triple‐Negative Breast Cancer. Advanced Science. 2026;13(10). doi:10.1002/advs.202513711
BibTeX
@article{Zhao2026,
author = {Zhao, Yujie and Yu, Jing and Wang, Xin and Liu, Xu and Zuo, Fengli and Xu, Tianyue and Tang, Leyi and Xiong, Ling and Li, Li and Li, Huifang and Chen, Xiaoting and Yang, Guang and Jing, Jing and Liu, Xiaowei},
title = {Combined Photothermal and mTOR‐Targeted Therapy Overcomes Immune Evasion and Enhances Checkpoint Blockade Efficacy in Metastatic Triple‐Negative Breast Cancer},
journal = {Advanced Science},
year = {2026},
volume = {13},
number = {10},
doi = {10.1002/advs.202513711}
}
EUVIMED